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end ot December 2000 (each patient had made
measurement once or two or three times).
Semiconductor detectors (with OPD 510 by
Scanditronix) were used during in-vivo dosimetry.
Doses were calculated and measured in (1) the
centre ot the irradiation tield; (2) supraclavicular
region; (3) mediastinum; (4) lower edge ot the
tield and (5) necko Patients were irradiated at
various accelerators, most ot them at Neptun with
photons 9 MeV.
Results: Ali patients were divided into three
groups. The criterion of inclusion was the per
cent difference between calculated and
measured doses average for all dosimetrical
points. The ranges for the groups were: 0-5%, 5-
10% and over 10 %. The mean per cent
differences in the first group of 43 patients was
3.1 %, in second of 27 patients - 6.3%, and in
third of 6 patients - 17.6% respectively. There
was no elear reason, beside an aeeidental error
why for the eertain patient difference was much
larger than for the another. Mean difference tor
all groups was equal to 5.3%.
In the table mean per cent differences
between doses calculated and measured and
their standard deviations (SD) in the whole
group ot patients are shown tor central axis,
mediastinum and supraclavicular region.
central axis mediastinum
supraclavicular
region
Mean diff. SD Mean diff. SD Mean diff. SD
1.5% 4.1% -0.3% 4.6% 2.0% 5.7%
Conclusion: Mean difference in the whole
group of patients showsgood agreement
between pre-calculated and measured doses,
especially for three clinically important regions
(table). It is accompanied by low standard
deviation which is an indicator ot smali deviations
between doses inside the whole group.
6.
THE TECHNIQUE OF TOTAL BODY
IRRADIATION APPLlED IN THE ST.
LESZCZYŃSKI MEMORIAL HOSPITAL
IN KATOWICE
A.Kawa - Iwanicka, M. Dybek, T. Iwanieki,
W. Łobodziec, A. Radkowski
Radiotherapy Department of the Hospital -
Memorial Sto Leszczyński, Katowice
At the Sto Leszczyński Memorial Hospital in
Katowice a moditication ot TBI technique was
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prepared. For this a special two variant ot body
trame - one tor treatment planning and an
another one for treatment delivery - was made.
The total dose of 12 - 15 Gy (in lung not more
than 9 Gy) was delivered in six fraction of 15 MV
photons, produced in Primus Iinear accelerator,
for 3 consecutive days. Patient was treated by a
combination ot tields: lateral - set at SSO ot 330
cm and AP/PA - set at 135 cm. The dose-rate
measured at 10 cm in a water phantom for
(ateral tields was 4,3 cGy/min., and tor AP/PA
fields 23,6 cGy/min. Lung shields were made
from wood alloy and their shape was carried out
from computerized tomograph scans (CT). For
each patient a set of computerized tomograph
scans was prepared. Patient during the eT was
laying in supine position in the body trame made
of 1 cm thick plexi plates. On the walls of that
body frame a special marks ot tin materiał were
inserted. These marks allow to reproduce both -
the same patient position during the irradiation
and also in the treatment planning system
HELAX. Position of shields before AP/PA
fraction was determined by means ot HELAX,
and then shields were fastened to plexi trays
inserted in the head of Primus. Lung was also
shielded during one lateral fraction and the
shape ot the shield was carried· out on a
simulator. The volume between the patient and
walls of the body frame was fulfilled by bolus
(bags with rice) to get a homogenous dose
distribution. The electron boost to the thorax wall
(shielded for 15 MV photons) was delivered with
a 6 or 9 MeV electron beam.
The percentage deviation of dose, for all 9
irradiated patients, calculated at ten anatomical
points representative of the body anatomy, was
in the limit -0,4% to +13% (excluded in lung)
trom the dose delivered to PC (reterence point:
1/2 AP and 1/2 lateral dimension at 1/2 of
patient length in irradiation position). The in vivo
measurements carried out by means ot
MOSFET detectors confirmed that accuracy.
7.
IMRT NEW STANDARDS IN
TREATMENT PLANNING
A. Grządziel, K. Ślosarek, R. Rutkowski,
A. Rembielak
Treatment Planning Unit Center ot Oncology -
MSC Memoriallnstitute, Gliwice, Poland
Technological advances in medical imaging
have prompted accelerator manutactures to
produce more and more advanced treatment
delivery systems capable to preeise shape the
dole distribution.
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For several years radiation beams have been
modulated by mechanical and dynamie wedges,
compensators, individual shields and unequal
beam weights. Nowadays three dimensional
conformai treatment and intensity modulated
radiation therapy techniques (IMRT) provide
very precise conformation of the dose to the
target volume while sparing adjacent healthy
tissues. On the other hand conformal
radiotherapy requires very precise definition of
anatomical structures, improved patient
repositioning systems. New challenge
represents quality control program and
treatment verification.
IMRT was introduced in c1inical practice in
Center of Oncology, Gliwice in year 2000. Such
treatment is delivered by Clinac 2300 with
dynamic MLC option, on the base of dose
distributions calculated by CadPlan-Helios
treatment planning system, and sent via Varis to
accelerator.
The aim of this paper is to present our
experience with IMRT technique with particular
regard to IMRT treatment plan (definition of PTV
and calculation factors like Termination
Tolerance, Priority Factor, Scatter Factor).
8.
EVALUATION OF A NEW SYSTEM
FOR IN-VIVO DOSIMETRY BASED ON
MOSFET DETECTORS
P.F. Kukołowicz, K. Buliński, K. Lis,
J. Miedzińska
Holycross Cancer Centre, Medical Physics
Department, Kielce, Poland
Purpose: In Holycross Cancer Centre in
Kielce in vivo dosimetry is performed with new
miniature detectors called MOSFET. MOSFETs
are advertised by Thomson &Nielsen company
as almost ideal detector for in-vivo dosimetry:
they are isotropie, can be treated as point
detector fully transparent to treatment beam,
having zero temperature and negligible energy
effect, can be used either for electron and
photon radiation, in teletherapy and
brachytherapy, can be used in sęveral QA
procedures, very easy and convenient for
handling and very low time consuming. Our
experience both from extensive tests and clinical
use will be presented.
Results: From our experience MOSFETs
detectors can be treated as isotropie, are fully
transparent for radiation, can be used both in
teletherapy and brachyterapy. For application in
3D
brachyterapy special catheters with lead
localisation markers must be used. The energy
dependence cannot be considered as negligible.
For 6 and 15 MV X photons calibration factors
differ of about 5%. Reproducibility depends
strongly on the dose. It decreases very much for
very smali doses (for dose 60 cGy - 1 standard
deviation is of 2,5%). Very useful advantage of
MOSFET detectors is their applicability for
surface dose measurements. More details will
be presented during the congress.
Conclusion: MOSFET detectors can be
effectively used for in-vivo dosimetry in tele and
brachytherapy. The reproducibility should be
improved.
9.
COMPARISON BETWEEN CONVEN-
TIONAL SIMULATOR PLANNING AND
CONFORMAL 3-D PLANNING FOR
CERVICAL CANCER TELETHERAPY
K. Bratos, A. Roszak, E. Cikowska-Woźniak,
T.Piotrowski
Wielkopolskie Centrum Onkologii, Poznań,
Poland
The using of simulator planning based on
bony landmarks for pelvic irradiation of cervix
cancer is associated with a risk in a
geographical miss, which may be generated by
inadequate knowledge of the individual
anatomy. 3D treatment planning system let us
know an individual topography of pelvic organs,
enables to mark a PTV and it allows more
adequate coverage. PURPOSE The aim of this
study was to evaluate a benefit resulting from
3D treatment planning for teletherapy of cervical
cancer. MATERIAL AND METHOD In our study
on 15 patients with cervical carcinoma in the
stage IIIB simulator planning of "box" technique
was performed. Next we defined the PTV in 3D-
planning system and compared the dose
distribution, obtained with both methods, in the
target volumes and organs at risk using dose-
volume histograms. RESULTS In 4 of 15
patients the encompassment of the PTV by the
treated volume was inadequate in case of
simulator planning. The treated volumes based
on 3D-planning were 8% smaller than volumes
based on simulator planning. The treated
volume/ planning target volume ratio was 1,64
for simulator planning and 1,50 for 3D planning.
3D-planning system resulted in a reduction of
the irradiated bladder volume(-12%) and the
bowel volume (-9%). The bladder and bowel
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